Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.427 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.429 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.166EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.467EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.74 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used